Epithalon

A synthetic tetrapeptide from the long-running Russian bioregulator programme, where decades of studies reported telomerase activation and improved survival in elderly cohorts. Those results are intriguing but come largely from one research group, without independent replication yet.

Reported to activate telomerase and influence circadian/pineal regulation in the originating research; independent confirmation of the human mechanism is pending.

Decades of single-group human data report positive longevity outcomes; independent replication is the missing piece.

Community reports vary. Anecdotal and unvalidated; general information only.

General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.

• Not well characterised in independent studies

• USNot FDA-approved for human use.

Legal status changes over time; verify locally before relying on this.

Does epithalon extend lifespan?

The originating Russian research reported reduced mortality in elderly cohorts over multi-year follow-ups — genuinely interesting results. They come largely from a single research group, so independent replication is what the field is waiting on.

Is epithalon approved?

No — it is not FDA-approved for human use.

• Epithalon researchPubMed

• SS-31 (Elamipretide)
• Humanin
• Glutathione

See all Longevity peptides →